Follow-up assessment of patients with Pure Neural Leprosy in a reference center in Rio de Janeiro-Brazil

PLoS Negl Trop Dis. 2022 Jan 11;16(1):e0010070. doi: 10.1371/journal.pntd.0010070. eCollection 2022 Jan.

Abstract

Introduction: Pure Neural Leprosy (PNL) is a rare clinical form of leprosy in which patients do not present with the classical skin lesions but have a high burden of the disability associated with the disease. Clinical characteristics and follow up of patients in PNL are still poorly described in the literature.

Objective: This paper aims to describe the clinical, electrophysiological and histopathological characteristics of PNL patients, as well as their evolution after multidrug therapy (MDT).

Methods: Fifty-two PNL patients were selected. Clinical, nerve conduction studies (NCS), histopathological and anti-PGL-1serology were evaluated. Patients were also assessed monthly during the MDT. At the end of the MDT, all of the patients had a new neurological examination and 44 were submitted to another NCS.

Results: Paresthesia was the complaint most frequently reported by patients, and in the neurological examination the most common pattern observed was impairment in sensory and motor examination and a mononeuropathy multiplex. Painful nerve enlargement, a classical symptom of leprosy neuropathy, was observed in a minority of patients and in the motor NCS axonal injuries, alone or in combination with demyelinating features, were the most commonly observed. 88% of the patients did not present any leprosy reaction during MDT. There was no statistically significant difference between the neurological examinations, nor the NCS pattern, performed before and after the MDT.

Discussion: The classical hallmarks of leprosy neuropathy are not always present in PNL making the diagnosis even more challenging. Nerve biopsy is an important tool for PNL diagnosis as it may guide therapeutic decisions. This paper highlights unique characteristics of PNL in the spectrum of leprosy in an attempt to facilitate the diagnosis and management of these patients.

MeSH terms

  • Brazil
  • Drug Therapy, Combination
  • Female
  • Humans
  • Leprostatic Agents / therapeutic use
  • Leprosy, Tuberculoid / diagnosis*
  • Leprosy, Tuberculoid / drug therapy
  • Leprosy, Tuberculoid / pathology*
  • Male
  • Middle Aged
  • Mycobacterium leprae / isolation & purification
  • Neural Conduction / physiology*
  • Paresthesia / pathology
  • Polyneuropathies / diagnosis*
  • Polyneuropathies / microbiology
  • Polyneuropathies / pathology

Substances

  • Leprostatic Agents

Grants and funding

The author(s) received no specific funding for this work.